Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | PDS0101 |
Synonyms | |
Therapy Description |
PDS0101 is a cancer vaccine comprising 6 HPV-16 E6 and E7 peptides encapsulated in a lipid nanoparticle, which potentially stimulates anti-tumor immune response (PMID: 32554612). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
PDS0101 | PDS 0101|PDS-0101 | PDS0101 is a cancer vaccine comprising 6 HPV-16 E6 and E7 peptides encapsulated in a lipid nanoparticle, which potentially stimulates anti-tumor immune response (PMID: 32554612). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05232851 | Phase Ib/II | PDS0101 + Pembrolizumab PDS0101 | A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer | Recruiting | USA | 0 |